Heterocyclic compounds and their use as ampk activators
GB0903125D0
Screening assay and kits therefor
US2011177046A1
Dithiazolidine and thiazolidine derivatives as anticancer agents
WO2008090356A1
Thiazolidinone derivatives useful in the treatment of cancer and disorders caused by excess adiposity
WO2008090327A1
New combination for use in the treatment of cancer
WO2008065409A2
Combination for use in the treatment of cancer, comprising tamoxifen or an aromatase inhibitor
WO2007099345A1
Medical use of bmp-2 and/ or bmp-4
BRPI0613751A2
use of a pharmaceutically acceptable compound, salt or solvate, a pharmaceutically functional derivative thereof, compound or a pharmaceutically acceptable salt or salvate thereof, or a functional derivative thereof, pharmaceutical formulation, cancer treatment method, and combined product
ZA200800243B
Use of thiazole derivatives and analogues in the treatment of cancer
CA2615752A1
Use of thiazole derivatives and analogues in the treatment of cancer
EP1812559A1
A method for differentiation of pancreatic stem cells into insulin producing cells
WO2006038865A1
Nucleotide derivatives for the treatment of type 2 diabetes and other disorders
WO2004020672A1
Targets for type i and type ii diabetes
CA2414652A1
Animal and cell models for type ii diabetes and their use
